EP0328282A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Pharmaceutical
Assignee: Zeneca Inc
•
Filing: 1989-01-30
•
Granted: —
•
Expires: 2009-01-30
Abstract
Abstract The invention relates to a method of using a compound of formula Ia <CHEM> to antagonize the effects of benzodiazepine receptor agonists.
Inventors
- 👤 James Franklin Resch
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-26 21:53
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/50; A61K31/55; A61P; A61P25/00
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
35 words
The use of 4-amino-8-phenyl- N -propyl-3-cinnoline-carboxamide, or of a non-toxic pharmaceutically acceptable salt thereof, for the manufacture of a novel medicament for antagonizing one or more of the pharmacological effects of a benzodiazepine receptor agonist.
Claim 2
Dependent Claim
35 words
The use of 4-amino-8-phenyl- N -propyl-3-cinnoline-carboxamide, or of a non-toxic pharmaceutically acceptable salt thereof, for the manufacture of a novel medicament for antagonizing one or more of the pharmacological effects of a benzodiazepine receptor agonist.
Claim 3
Dependent Claim
19 words
The use as claimed in Claim 1 wherein the non-toxic pharmaceutically acceptable salt is a physiologically acceptable acid-addition salt.
Claim 4
Dependent Claim
27 words
The use as claimed in Claim 1 or 2 wherein the benzodiazepine is selected from chlordiazepoxide, diazepam, larazepam, prazepam, halazepam, oxazepam, chlorazapate, alprazolam, flurazepam, triazolam and temazepam.
Claim 5
Dependent Claim
14 words
The use as claimed in Claim 1 or 2 wherein the benzodiazepine is diazepam.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.